市場調查報告書
商品編碼
1541821
分叉病變市場報告(按類型(單支架、雙支架)、應用(冠狀血管、周邊血管)和地區)2024-2032Bifurcation Lesions Market Report by Types (One-Stent, Two-Stent), Application (Coronary Vascular, Peripheral Vascular), and Region 2024-2032 |
IMARC Group年,全球分叉病變市場規模達24億美元。
分叉病變是指鄰近重要側支(SB)起點的冠狀動脈變窄。由於血流湍流和高剪切應力,容易形成動脈粥狀硬化斑塊。使用分析、手術持續時間、X 光照射和長期追蹤等技術進行治療。此外,3D(3D)血管攝影和多層電腦斷層掃描用於測量分叉角。隨著設備、影像、輔助藥物治療和血管通路的進步,全球複雜的分叉病變病例的治療已成為可能。
冠狀動脈疾病(CAD)發生率的顯著增加增加了分叉病變的風險。這是推動市場成長的關鍵因素之一。除此之外,創新設備的批准、保險覆蓋範圍的擴大和成像方式的改進也正在加強市場的成長。此外,老年人口的增加(更有可能患上醫療疾病),以及各國政府為報銷而採取的支持性舉措,正在支持市場的成長。醫療旅遊業的成長、微創(MI)手術需求的不斷增加以及醫療基礎設施的改善是促進市場成長的其他因素。除此之外,正在進行的新型治療技術研究正在推動市場發展。例如,研究人員正在研究 Szabo 2 支架技術對具有高危害風險或 SB 閉塞致命後果的複雜分叉病變的有效性。此外,對支架和球囊的廣泛臨床試驗,加上熟練醫療保健專業人員數量的增加,預計將降低與分叉病變治療相關的風險,並對市場產生積極影響。
The global bifurcation lesions market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.
A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.
A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bifurcation lesions market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on types and application.
One-Stent
Two-Stent
Coronary Vascular
Peripheral Vascular
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.